supp.fit

Melatonin: study protocols

399 study groups say how much Melatonin participants took a day. These are the doses the studies gave. They are not a recommendation.

Melatonin: what the research found →

Dose per serving from products

3,861 products in our catalogue print how much Melatonin a serving holds.

Most common: 2.5 mg to 5 mg, 46% of 3,861 products.

Dose per servingProducts
500 mcg or less
113
500 mcg to 1 mg
448
1 mg to 2.5 mg
425
2.5 mg to 5 mg
1,760
5 mg to 10 mg
764
10 mg to 25 mg
183
over 25 mg
168

Dose per serving from research

384 study groups in 297 studies say how much Melatonin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mg to 5 mg, 40% of 384 study groups.

Daily doseStudy groups
250 mcg or less
9
250 mcg to 500 mcg
16
500 mcg to 1 mg
16
1 mg to 2.5 mg
43
2.5 mg to 5 mg
154
5 mg to 10 mg
85
10 mg to 25 mg
32
25 mg to 50 mg
19
over 50 mg
10

Commonly used together

19 of 399 study groups took Melatonin with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Zinc
4
Inositol
3

399 study groups

Study
Effects of Melatonin for Delirium in Elderly Acute Heart Failure Patients: A Randomized, Single-Center, Double-Blind, and Placebo-Controlled Trial
2022 · melatonin · Patients aged over 60 years after acute heart failure
3 mg7 days248
Effects of Melatonin on Postoperative Delirium After PCI in Elderly Patients: A Randomized, Single-Center, Double-Blind, Placebo-Controlled Trial
2021 · Mel group · Patients over age 60 admitted to intensive care units after PCI
3 mg7 days148
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
2023 · melatonin group · Adults aged 20 years or older with severe COVID-19 pneumonia admitted to the ICU
10 mg7 days109
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients
2022 · melatonin group · Hospitalized adults aged 18–79 with confirmed severe COVID-19
10 mg2 weeks82
The impact of melatonin on postoperative delirium in geriatric patients after colorectal surgery: a randomized placebo-controlled trial
2024 · Melatonin group · Elderly men and women undergoing elective colorectal cancer surgery under general anesthesia
10 mg1 day50
Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized control trial
2018 · intervention group · Newborns with gestational age of 34 weeks or higher and hypoxic ischaemic encephalopathy, presenting within 12 hours of birth
10 mg1 day40
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin
1992 · MLT · Adults with metastatic nonsmall cell lung cancer that progressed after first-line cisplatin-containing chemotherapy; age and sex not reported
10 mg—31
Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans
2011 · group B · H. pylori-positive adults aged 28–50 with gastric or duodenal ulcers
10 mg3 weeks14
Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension
1990 · IL-2 plus MLT · Metastatic renal cancer patients
10 mg5 days—
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
1999 · MLT plus chemotherapy · Adults with metastatic solid tumours and poor clinical status; age and sex not reported
20 mg—124
Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
2003 · chemotherapy and melatonin · Patients with metastatic non-small cell lung cancer; age and sex not stated
20 mg—49
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
1997 · chemotherapy plus melatonin · Adults with advanced non-small cell lung cancer and poor clinical status; age and sex not reported
20 mg—34
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations
2003 · CPT-11 plus MLT · Patients with metastatic colorectal cancer progressing after at least one previous 5-fluorouracil-containing chemotherapy line
20 mg9 weeks14
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
1996 · RT plus MLT · Patients with glioblastoma
20 mg—14
Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms
2007 · chemotherapy plus MLT · Patients with metastatic solid tumors, including non-small cell lung cancer or gastrointestinal tumors
20 mg——
Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors
2008 · supportive care plus MLT · Patients with untreatable metastatic non-small-cell lung cancer or gastrointestinal tract tumors
20 mg——
Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors
2008 · MLT plus SC low-dose IL-2 · Patients with untreatable metastatic non-small-cell lung cancer or gastrointestinal tract tumors
20 mg4 weeks—
Protective Effects of Melatonin on Kidney Function Against Contrast Media-Induced Kidney Damage in Patients With Chronic Kidney Disease: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial
2025 · melatonin group · Patients with chronic kidney disease undergoing coronary angiography
20 mg6 days—
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
1994 · supportive care plus melatonin · Patients with brain metastases due to solid neoplasms
20 mg——
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
1996 · melatonin-treated group · Patients with melanoma surgically treated for regional node recurrence after lymph node relapse
20 mg——
Does Melatonin Improve Sleep Following Primary Total Hip Arthroplasty? A Randomized, Double-Blind, Placebo-Controlled Trial
2025 · melatonin group · Patients undergoing primary elective total hip arthroplasty; age and sex not reported
5 mg2 weeks75
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
2016 · Melatonin 3 mg · Adults aged 18–65 with migraine, with or without aura
3 mg12 weeks60
Effect of melatonin on postoperative cognitive function in elderly patients submitted to transurethral resection of the prostate under spinal anesthesia
2025 · Melatonin group · Men aged over 60 with benign prostatic hyperplasia undergoing elective transurethral resection of the prostate under spinal anesthesia
10 mg4 days58
Comparison of the effects of preoperative melatonin or vitamin C administration on postoperative analgesia
2020 · group M (melatonin group) · Adults aged 18–65 years, ASA status I–II, undergoing elective major abdominal surgery
6 mg1 day55
Effect of add-on melatonin on seizure outcome, neuronal damage, oxidative stress, and quality of life in generalized epilepsy with generalized onset motor seizures in adults: A randomized controlled trial
2021 · test group · Adults with generalized epilepsy with generalized onset motor seizures
3 mg8 weeks52
Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial
2020 · 3 mg fast-release melatonin · Middle-aged patients with primary insomnia
3 mg4 weeks51
Efficacy of melatonin on sleep quality after laparoscopic cholecystectomy
2018 · Group A (melatonin group) · Adults aged 18–80 undergoing elective laparoscopic cholecystectomy
3 mg3 days50
Influence of Melatonin Treatment on Emotion, Sleep, and Life Quality in Perimenopausal Women: A Clinical Study
2023 · study group · Chinese women aged 45–55 with perimenopausal climacteric symptoms, sleep disorder, anxiety, and depression
3 mg15 weeks50
A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes
2014 · melatonin · Postmenopausal women with a history of primary breast cancer, ductal carcinoma in situ, or lobular carcinoma in situ who had completed active cancer treatment
3 mg120 days48
Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial
2016 · Melatonin treatment · Children and adolescents aged 1 to 18 years with physician-diagnosed atopic dermatitis involving at least 5% of total body surface area and sleep disturbance
3 mg4 weeks48
Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial
2021 · melatonin group · Adults over 18 with stable heart failure with reduced ejection fraction (HFrEF)
10 mg24 weeks46
Effect of melatonin and gabapentin on anxiety and pain associated with retrobulbar eye block for cataract surgery: a randomized double-blind study
2013 · melatonin group (group M) · Patients undergoing cataract surgery; age and sex range not specified
6 mg1 day40
[Effect of melatonin on the daytime sleepiness side-effect of gabapentin in adults patients with neuropathic pain]
2019 · Group 1 (melatonin+) · Adults with neuropathic pain receiving gabapentin; age range and sex not specified
3 mg30 days40
Melatonin and sleep parameters in infertile women with endometriosis: first results from the triple-blind randomized controlled trial of administration of melatonin in chronic pelvic pain and sleep disturbance
2025 · melatonin group · Infertile women aged 18–45 with laparoscopy-confirmed endometriosis, chronic pelvic pain and sleep disturbances
5 mg60 days40
Is dietary melatonin supplementation a viable adjunctive therapy for chronic periodontitis?-A randomized controlled clinical trial
2019 · Melatonin group · Patients with generalized chronic periodontitis and primary insomnia; ages and sex not specified
10 mg60 days38
Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag
2001 · melatonin · Volunteers travelling eastward from Switzerland to the American continent and back across 6–9 time zones; age and sex not reported; jet lag
5 mg5 days35
Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial
2017 · Group A (melatonin) · Patients with chronic migraine
3 mg60 days35
The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial
2018 · melatonin supplements · children aged 6–12 years diagnosed with atopic dermatitis
6 mg6 weeks35
Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of Gastroesophageal Reflux Disease Symptoms: A Clinical Trial
2023 · melatonin group · Adults older than 18 with mild to moderate gastroesophageal reflux disease symptoms
3 mg4 weeks35
The effects of melatonin on follicular oxidative stress and art outcomes in women with diminished ovarian reserve: a randomized controlled trial
2025 · Melatonin intervention group · Infertile women with diminished ovarian reserve undergoing their first assisted reproductive technology cycle; age range not reported
3 mg—35
Effects of fluoxetine and melatonin on mood, sleep quality and body mass index in postmenopausal women
2015 · Group II · Overweight postmenopausal women aged 54–65 years with increased appetite
5 mg24 weeks34
The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study
2023 · Melatonin, patients with sleep disorders · Adults of unrestricted age and sex with IBS diagnosed by Rome IV criteria and sleep disorders
6 mg8 weeks34
The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study
2023 · Melatonin, patients without sleep disorders · Adults of unrestricted age and sex with IBS diagnosed by Rome IV criteria and without sleep disorders
6 mg8 weeks34
Comparison of the effect of melatonin, dexmedetomidine, and gabapentin on reduction of postoperative pain and anxiety following laminectomy: a randomized clinical trial
2022 · melatonin group (M) · Adults aged 40–60 years with ASA physical status I–II undergoing laminectomy at one or two levels
10 mg1 day33
A prospective randomized crossover trial investigating melatonin versus sleep deprivation for sleep induction in nap electroencephalography
2026 · melatonin · Children aged 6 years and older weighing at least 15 kg, with well-controlled epilepsy or suspected epilepsy and/or EEG abnormalities
5 mg1 day33
A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19
2022 · melatonin · Patients with mild-to-moderate COVID-19 symptoms
10 mg2 weeks32
Role of melatonin in attenuation of hemodynamic response to intubation and anesthetic requirements: a randomized, controlled, double-blind study
2023 · melatonin group · Adults aged 18–60 years, either sex, ASA physical status I/II, scheduled for elective laparoscopic cholecystectomy under general anesthesia
3 mg1 day31
Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial
2022 · melatonin · Patients with Parkinson's disease and subjective sleep complaints
3 mg4 weeks31
Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway
2007 · melatonin · Patients with subjective tinnitus; age and sex not reported
3 mg30 days30
Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis
2011 · group I · Adults aged 26–49 with left-sided ulcerative colitis in clinical remission for the previous 12 months
5 mg1 year30
The effects of melatonin on anxiety and pain scores of patients, intraocular pressure, and operating conditions during cataract surgery under topical anesthesia
2013 · M group · Adults aged 25–80 undergoing elective cataract surgery under topical anesthesia; ASA physical status I–III
3 mg1 day30
The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
2020 · melatonin · Diabetic hemodialysis patients aged 18–80 years
10 mg12 weeks30
Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial
2020 · melatonin group · Adults with Parkinson's disease; age and sex not specified
10 mg12 weeks30
Effect of add-on melatonin on seizure outcomes and quality of sleep in epilepsy with idiopathic generalized tonic-clonic seizures alone in adult patients: Cross-sectional, randomized, double-blind, placebo-controlled clinical trial
2023 · melatonin + valproic acid · Adults aged 18–60 with idiopathic generalized tonic-clonic seizures, receiving valproic acid
3 mg8 weeks30
The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial
2024 · Melatonin group · Adults aged 20–57 with migraine
3 mg60 days30
Effect of melatonin on tinnitus
1998 · melatonin treatment · Adults with subjective tinnitus
3 mg30 days30
Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag
2001 · combination melatonin/zolpidem · Volunteers travelling eastward from Switzerland to the American continent and back across 6–9 time zones; age and sex not reported; jet lag
5 mg5 days29
Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
2019 · 10 mg melatonin · Women aged 18–40 years with polycystic ovary syndrome (PCOS)
10 mg12 weeks29
Melatonin supports nonsurgical periodontal treatment in patients with Type 2 diabetes mellitus and periodontitis: A randomized clinical trial
2024 · full-mouth scaling and root planing plus melatonin (fmSRP-mel) · Adults with type 2 diabetes mellitus and stage III/IV, grade C periodontitis
6 mg30 days28
Melatonin improves memory acquisition under stress independent of stress hormone release
2009 · melatonin · healthy young men
3 mg1 day27
Adjuvant use of melatonin for treatment of fibromyalgia
2011 · group B · Patients with fibromyalgia syndrome; age and sex distribution by arm not reported
5 mg8 weeks27
Adjuvant use of melatonin for treatment of fibromyalgia
2011 · group C · Patients with fibromyalgia syndrome; age and sex distribution by arm not reported
3 mg8 weeks27
Effect of Melatonin on Sleep in the Perioperative Period after Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial
2016 · melatonin · Patients undergoing breast cancer surgery; adult age and sex details not stated
6 mg2 weeks27
Exogenous melatonin decreases circadian misalignment and body weight among early types
2021 · melatonin · Overweight female nurses working night shifts, with a mean age of 37.1 years and mean BMI of 29.9 kg/m²; analyses considered chronotype
3 mg12 weeks27
The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment
2019 · melatonin · Patients under methadone maintenance treatment; age and sex not specified
10 mg12 weeks26
The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial
2020 · melatonin group · Patients with non-alcoholic fatty liver disease; age range and sex not stated
6 mg12 weeks24
Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial
2022 · intervention group · Adults aged 18 years or older, male and non-pregnant female patients hospitalized with mild to moderate COVID-19
9 mg2 weeks24
Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance
2003 · time-released melatonin · Adults aged 21–53 years, 9 men and 14 women; no condition stated
6 mg1 day23
Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam
2004 · time-released melatonin · Men and women aged 21–53 years; no specific condition stated
6 mg1 day23
Adjuvant use of melatonin for treatment of fibromyalgia
2011 · group D · Patients with fibromyalgia syndrome; age and sex distribution by arm not reported
5 mg8 weeks23
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study
2001 · melatonin treatment group · patients with schizophrenia and tardive dyskinesia
10 mg6 weeks22
Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study
2009 · melatonin · Adults over 65 with a history of sleep disorder complaints; 7 men and 15 women enrolled
5 mg60 days22
The effect of melatonin in patients with fibromyalgia: a pilot study
2000 · melatonin treatment · Adults with fibromyalgia; age range and sex not specified
3 mg4 weeks21
Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial
2014 · melatonin · Adults aged 18 years or older with fibromyalgia, refractory to their current treatment
10 mg6 weeks21
Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial
2014 · amitriptyline + melatonin · Adults aged 18 years or older with fibromyalgia, refractory to their current treatment
10 mg6 weeks21
Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial
2001 · melatonin · Children aged 6–12 years with chronic sleep onset insomnia lasting more than 1 year
5 mg4 weeks20
Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia
2003 · 3.0 mg melatonin · People with intellectual disability and sleep deficits/insomnia; age and sex not reported
3 mg7 days20
Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study
2005 · melatonin · Adults aged 20–64 with irritable bowel syndrome and sleep disturbances
3 mg2 weeks20
Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia
2009 · melatonin group · Patients undergoing cataract surgery under topical anesthesia; age and sex not stated
10 mg1 day20
[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam]
2012 · Group 1 · Adults with Parkinson's disease without dementia and sleep-disorder complaints; mean age 67.3 years; 15 males and 23 females across the study
3 mg6 weeks20
Premedication with oral alprazolam and melatonin combination: a comparison with either alone--a randomized controlled factorial trial
2014 · Group one: combination of alprazolam and melatonin · Patients aged 18–65 with anxiety scheduled for general anesthesia for laparoscopic cholecystectomy
3 mg1 day20
Premedication with oral alprazolam and melatonin combination: a comparison with either alone--a randomized controlled factorial trial
2014 · Group three: melatonin · Patients aged 18–65 with anxiety scheduled for general anesthesia for laparoscopic cholecystectomy
3 mg1 day20
Comparison of the Effects of Melatonin and Oxazepam on Anxiety Levels and Sleep Quality in Patients With ST-Segment-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial
2018 · melatonin group · Patients with ST-segment-elevation myocardial infarction following primary percutaneous coronary intervention
3 mg—20
The Effect of Preoperative Oral Melatonin on Postoperative Pain after Lumbar Disc Surgery: A Double-Blinded Randomized Clinical Trial
2022 · Group B (5 mg melatonin) · Adults aged 35–70 undergoing lumbar laminectomy and discectomy
5 mg1 day20
The Effect of Preoperative Oral Melatonin on Postoperative Pain after Lumbar Disc Surgery: A Double-Blinded Randomized Clinical Trial
2022 · Group C (10 mg melatonin) · Adults aged 35–70 undergoing lumbar laminectomy and discectomy
10 mg1 day20
Melatonin administered postoperatively lowers oxidative stress and inflammation and significantly recovers heart function in patients undergoing CABG surgery
2025 · Group 1 (ML1) · Adults aged 30–70 undergoing elective CABG surgery
5 mg60 days20
Melatonin administered postoperatively lowers oxidative stress and inflammation and significantly recovers heart function in patients undergoing CABG surgery
2025 · Group 2 (ML2) · Adults aged 30–70 undergoing elective CABG surgery
10 mg60 days20
Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures
1999 · melatonin · 20 young healthy adults aged about 23.5 years, male and female
5 mg1 day20
The Effect of Preoperative Oral Melatonin on Postoperative Pain after Lumbar Disc Surgery: A Double-Blinded Randomized Clinical Trial
2022 · Group A (3 mg melatonin) · Adults aged 35–70 undergoing lumbar laminectomy and discectomy
3 mg1 day19
Randomized placebo-controlled field study of the effects of bright light and melatonin in adaptation to night work
2007 · melatonin · 17 oil-rig shift workers; age, sex, and medical condition not reported
3 mg8 days17
The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy
2007 · oral melatonin · Women undergoing abdominal hysterectomy, ASA physical status I-II; age not reported
10 mg1 day17
The effects of melatonin on colonic transit time in normal controls and IBS patients
2009 · Healthy controls · Healthy adults; age and sex not reported
3 mg30 days17
The effects of melatonin on colonic transit time in normal controls and IBS patients
2009 · Melatonin phase · Adults with irritable bowel syndrome; age and sex not reported
3 mg8 weeks17
Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial
2022 · Melatonin treatment · Men aged 40–70 years with type 2 diabetes; Caucasian, with BMI 25–35 kg/m² at diagnosis
10 mg12 weeks17
Melatonin reduces arousal and startle responsiveness without influencing startle habituation or affective startle modulation in young women
2008 · melatonin · healthy young women
4 mg1 day16
Effect of daytime oral melatonin administration on neurobehavioral performance in humans
1998 · Melatonin · Healthy young adults, mean age 22.4 years; 10 males and 6 females
5 mg1 day16
Melatonin treatment for age-related insomnia
2001 · 3.0 mg melatonin · Adults over 50 with actigraphically confirmed decreased sleep efficiency (insomniac subjects)
3 mg7 days15
Melatonin treatment for age-related insomnia
2001 · 3.0 mg melatonin · Adults over 50 who slept normally
3 mg7 days15
Melatonin and jet lag: confirmatory result using a simplified protocol
1992 · melatonin · Travelers on an eastward flight from North America to France; age and sex not stated
8 mg4 days15
12-week melatonin supplementation improved dynamic postural stability and walking performance in persons living with multiple sclerosis: A randomized controlled trial
2025 · melatonin group (MG) · Persons with multiple sclerosis
3 mg12 weeks15
Effects of Melatonin Supplementation on Muscle Strength, Manual Dexterity, and Postural Balance in Patients Living with Multiple sclerosis - A Randomized Controlled Trial
2025 · melatonin group (MG) · Patients with multiple sclerosis; age and sex not reported
3 mg12 weeks15
Melatonin influences human balance
1999 · 10 mg melatonin study · healthy volunteers; age and sex not reported
10 mg1 day14
Melatonin ingestion after exhaustive late-evening exercise attenuate muscle damage, oxidative stress, and inflammation during intense short term effort in the following day in teenage athletes
2020 · melatonin · Healthy-trained male teenage athletes
10 mg1 day14
Melatonin and zopiclone as pharmacologic aids to facilitate crew rest
2001 · 10 mg melatonin · 13 transport aircrew subjects; age and sex not reported; no condition specified
10 mg1 day13
Melatonin and zopiclone: the relationship between sleep propensity and body temperature
2002 · melatonin · 12 healthy young adults, 20.3 ± 0.6 years; 7 male and 5 female
5 mg1 day12
Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial
2008 · Melatonin · Critically ill adults with acute respiratory failure requiring mechanical ventilation and tracheostomy to assist weaning
10 mg4 days12
Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease
2008 · melatonin · Patients with moderate to very severe COPD; age and sex not specified
3 mg3 weeks12
Melatonin attenuates the vestibulosympathetic but not vestibulocollic reflexes in humans: selective impairment of the utricles
2010 · melatonin, study 1 · healthy adults aged 28 ± 1 years; 6 men and 6 women
3 mg1 day12
Melatonin attenuates the skin sympathetic nerve response to mental stress
2013 · melatonin · 12 healthy subjects
3 mg1 day12
Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study
2015 · Melatonin · Pre-pubertal children aged 6–11 years with epilepsy and sleep difficulties
9 mg4 weeks11
Daytime sleep and performance following a zolpidem and melatonin cocktail
2005 · zolpidem 0 mg plus melatonin 5 mg · Adults; sex and health condition not specified
5 mg1 day10
Daytime sleep and performance following a zolpidem and melatonin cocktail
2005 · zolpidem 5 mg plus melatonin 5 mg · Adults; sex and health condition not specified
5 mg1 day10
Daytime sleep and performance following a zolpidem and melatonin cocktail
2005 · zolpidem 10 mg plus melatonin 5 mg · Adults; sex and health condition not specified
5 mg1 day10
Daytime sleep and performance following a zolpidem and melatonin cocktail
2005 · zolpidem 20 mg plus melatonin 5 mg · Adults; sex and health condition not specified
5 mg1 day10
Melatonin attenuates the vestibulosympathetic but not vestibulocollic reflexes in humans: selective impairment of the utricles
2010 · melatonin, study 2 · healthy adults aged 26 ± 1 years; 4 men and 6 women
3 mg1 day10
Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study
2012 · melatonin phase · Patients aged 9 to 32 years with intractable epilepsy
10 mg3 weeks10
Melatonin ingestion after exhaustive late-evening exercise improves sleep quality and quantity, and short-term performances in teenage athletes
2018 · MEL-10 mg · Male adolescent athletes, mean age 15.4 years, described as healthy
10 mg1 day10
Daytime melatonin and light independently affect human alertness and body temperature
2019 · Melatonin intervention · Healthy adults aged 20–30 years, 5 female and 5 male, without reported health or sleep problems
5 mg1 day10
Melatonin supplementation improves psychomotor and physical performance in collegiate student-athletes following a sleep deprivation night
2021 · melatonin · Trained male collegiate student-athletes, mean age 20 years, tested under sleep-deprivation conditions
6 mg1 day10
Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups
1996 · oral melatonin · Cluster headache patients (2 with primary chronic cluster headache and 18 with episodic cluster headache); age and sex not reported
10 mg2 weeks10
Complex effects of melatonin on human circadian rhythms in constant dim light
1997 · Melatonin · 10 normal, healthy males
5 mg15 days10
Caffeine or melatonin effects on sleep and sleepiness after rapid eastward transmeridian travel
2004 · melatonin (Mlt) · Nine subjects after a seven-time-zone eastbound flight; age and sex not reported
5 mg5 days9
A preliminary study of melatonin in irritable bowel syndrome
2007 · melatonin · Adults aged 18 to 65 with irritable bowel syndrome
3 mg8 weeks9
Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis--a randomized, double-blind placebo-controlled study
2010 · 3 mg melatonin · Clinically stable patients with cystic fibrosis; mean age 16.6 years
3 mg3 weeks9
Delayed sleep phase syndrome response to melatonin
1991 · melatonin · 8 subjects with delayed sleep phase syndrome attending a sleep disorders clinic
5 mg4 weeks8
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder
2010 · melatonin · Males with polysomnographically confirmed REM sleep behaviour disorder (mean age 54 years)
3 mg4 weeks8
Sleep disruption in tetraplegia: a randomised, double-blind, placebo-controlled crossover trial of 3 mg melatonin
2014 · melatonin · Adults with complete tetraplegia; mean age 49.5 years
3 mg3 weeks8
Therapeutic benefit of melatonin in refractory central serous chorioretinopathy
2015 · melatonin · Patients with chronic central serous chorioretinopathy (CSCR), with visual acuity of 20/40 or worse in the affected eye or an incapacitating scotoma
9 mg30 days8
A relationship between heat loss and sleepiness: effects of postural change and melatonin administration
1997 · Melatonin administration · Eight healthy young men
5 mg1 day8
Actigraphy in agitated patients with dementia. Monitoring treatment outcomes
2007 · 3 mg melatonin · Patients with probable dementia of the Alzheimer type and agitated behaviour
3 mg2 weeks7
The hypnotic effects of melatonin treatment on diurnal sleep in humans
1999 · melatonin · six healthy male students
10 mg1 day6
Premedication with melatonin: a double-blind, placebo-controlled comparison with midazolam
1999 · melatonin · adult women undergoing anaesthesia; age range and condition not specified
5 mg1 day—
A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome
2001 · melatonin · Patients with delayed sleep phase syndrome
5 mg4 weeks—
The effects of bright light and nighttime melatonin administration on cardiac activity
2001 · melatonin · 16 young healthy subjects; age range and sex not stated
5 mg1 day—
Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial
2003 · melatonin · Children aged 6–12 years with idiopathic chronic sleep-onset insomnia
5 mg4 weeks—
Melatonin in patients with reduced REM sleep duration: two randomized controlled trials
2004 · melatonin · Adults, five women and nine men, mean age 50 years, with unselected neuropsychiatric sleep disorders and reduced REM sleep duration
3 mg4 weeks—
Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial
2004 · oral synthetic fast-release MLT · Children, adolescents and young adults aged 3.6–26 years with mental retardation and wake-sleep disorder, most with epileptic seizures
3 mg——
Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance
2004 · melatonin group · Patients undergoing laparoscopic cholecystectomy; age and sex not specified
5 mg1 day—
Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study
2005 · melatonin · Female patients with irritable bowel syndrome meeting Rome II criteria
3 mg8 weeks—
Melatonin premedication and the induction dose of propofol
2007 · M3 group · Adults undergoing different surgical procedures
3 mg1 day—
Melatonin premedication and the induction dose of propofol
2007 · M5 group · Adults undergoing different surgical procedures
5 mg1 day—
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study
2007 · melatonin · Patients with Parkinson's disease, Hoehn & Yahr stages I to III; age and sex not specified
3 mg4 weeks—
Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial
2007 · Melatonin · Adults enrolled in a benzodiazepine withdrawal programme at a methadone maintenance clinic
5 mg6 weeks—
Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease
2008 · LM (morning bright-light exposure plus evening melatonin) · Institutionalized adults with probable Alzheimer’s disease and rest–activity rhythm disruption; ages 60–100, both sexes
5 mg10 weeks—
The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study)
2009 · melatonin · Haemodialysis patients; six women, median age 71 years
3 mg6 weeks—
Melatonin: can it stop the ringing?
2011 · melatonin · Adults with chronic tinnitus
3 mg30 days—
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study
2014 · melatonin group · Patients with first-episode schizophrenia eligible for olanzapine treatment
3 mg8 weeks—
Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial
2015 · melatonin · Critically ill adults in the ICU, mechanically ventilated for more than 48 hours and with Simplified Acute Physiology Score II greater than 32
6 mg——
Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial
2016 · 3 mg melatonin nightly · Postmenopausal women; age range not reported
3 mg1 year—
Melatonin premedication versus placebo in wisdom teeth extraction: a randomised controlled trial
2015 · melatonin · Adults aged 21–65 undergoing elective extraction of all four wisdom teeth under general anaesthesia; ASA physical status I or II
6 mg1 day—
Melatonin effects on myocardial ischemia-reperfusion injury: Impact on the outcome in patients undergoing coronary artery bypass grafting surgery
2016 · low dose melatonin treatment group (M1) · Patients undergoing elective coronary artery bypass graft surgery
10 mg——
Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial
2020 · melatonin group · Patients with acute manic episodes associated with bipolar disorder
6 mg6 weeks—
The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial
2020 · melatonin group · Adults admitted to the ICU and receiving analgesics and/or sedatives
10 mg7 days—
Evaluation of Antipruritic Effect of Melatonin on Hemodialysis Patients with Uremic Pruritus, A Double-Blind, Randomized, Crossover Trial
2021 · melatonin period · Adults receiving hemodialysis with uremic pruritus
5 mg2 weeks—
Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled trial
2021 · melatonin group · Patients with rheumatoid arthritis; age and sex not reported
6 mg12 weeks—
The effect of Melatonin on Improving the benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial
2022 · treatment group · men aged 50 years or older with benign prostatic hyperplasia symptoms and IPSS ≥ 8
3 mg30 days—
High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults
2022 · high-dose melatonin condition · Healthy adults aged 55–78 years without major sleep complaints; 13 women and 11 men across the study
5 mg12 days—
The Effect of Melatonin on Analgesia, Anxiety, and Intraocular Pressure (IOP) in Cataract Surgery Under Topical Anesthesia
2023 · melatonin group · Patients aged 50 to 80 undergoing cataract surgery under topical anesthesia
3 mg1 day—
The effect of treatment with melatonin on primary school aged children with difficulty in initiation and maintenance of sleep
2022 · intervention group · Children aged 7–12 with sleep problems/insomnia
3 mg30 days—
Study of Exogenous Melatonin as a Treatment Modality for Sleep and Psychiatric Disorders in Hemodialysis Patients
2022 · melatonin-treated group · Adults with stable hemodialysis and sleep disorders (PSQI score ≥5); age and sex not reported
3 mg90 days—
Targeting Side Effects Associated with Androgen Deprivation Therapy Using Melatonin: A Randomized Trial on Hot Flashes and Sexual Health in Prostate Cancer Patients
2026 · melatonin · Prostate cancer patients experiencing hot flashes or sexual dysfunction due to androgen deprivation therapy
6 mg4 weeks—
Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil
1996 · melatonin plus placebo · young healthy adult males
3 mg1 day—
Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil
1996 · melatonin plus flumazenil · young healthy adult males
3 mg1 day—
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
1998 · 5-mg fast-release (FR) formulation · Volunteers who had flights over 6 to 8 time zones; age and sex not stated
5 mg4 days—
Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial
2011 · melatonin group · Adults aged 65 years or over admitted through the emergency department to a medical unit
500 mcg2 weeks72
A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour
1995 · IL-2 plus melatonin · Adults with untreatable metastatic solid tumours for whom no standard therapy was available
40 mg4 weeks52
Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin
1996 · Melatonin with IL-2 · Adults with advanced solid tumours receiving IL-2 cancer biotherapy
40 mg5 weeks45
A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
1994 · IL-2 + MLT · Adults aged 36–74 with advanced solid tumours other than renal cell cancer and melanoma
40 mg—41
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer
1994 · Immunotherapy · Patients with locally advanced or metastatic non-small cell lung cancer
40 mg—31
Comparison Between Efficacy of Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures: A Randomized Clinical Trial
2019 · melatonin group · Children aged 6–50 months with recurrent simple febrile seizures
0.9 mg/kg3 days30
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates
1995 · low-dose subcutaneous IL-2 plus melatonin · Adults with metastatic colorectal cancer who did not respond or progressed after first-line 5-FU and folates
40 mg4 weeks25
Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin
1996 · Melatonin with TNF · Adults with advanced solid tumours receiving TNF cancer biotherapy
40 mg12 days23
Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study
2015 · melatonin/hypothermia group · Term newborns with hypoxic-ischemic encephalopathy
10 mg/kg5 days15
Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation
2017 · Melatonin group · Adults with head and neck cancer receiving concurrent chemoradiation
20 mg7 weeks—
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
2010 · prolonged-release melatonin (PRM) group · Men and women aged 18–80 years with primary insomnia; efficacy was also assessed in low melatonin excretors and adults aged 65–80 years.
2 mg29 weeks373
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes
2007 · PR-melatonin · Males and females aged 55–80 years with primary insomnia
2 mg3 weeks177
A Randomized, Controlled, Parallel-Group, Trial on the Long-term Effects of Melatonin on Fatigue Associated With Breast Cancer and Its Adjuvant Treatments
2023 · intervention group (oral melatonin) · Female patients with stage I–III invasive breast cancer receiving adjuvant chemotherapy and radiotherapy
18 mg125 weeks102
Exogenous melatonin's effect on salivary cortisol and amylase: A randomized controlled trial
2024 · Melatonin group · Healthy adult volunteers aged 19–75, without underlying disease; men and women
2 mg1 day64
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life
2019 · PedPRM · Children and adolescents aged 2–17.5 years with autism spectrum disorder or Smith-Magenis syndrome and chronic sleep disturbances
2 mg13 weeks58
Melatonin treatment has consistent but transient beneficial effects on sleep measures and pain in patients with severe chronic pain: the DREAM-CP randomised controlled trial
2024 · Melatonin treatment period (Circadin™) · Adults with severe chronic non-malignant pain of at least 3 months’ duration; ages 24–79 in the enrolled groups
2 mg6 weeks58
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder
2021 · PedPRM group · Children and adolescents aged 2–17.5 years with autism spectrum disorder or Smith-Magenis syndrome and impaired sleep
2 mg104 weeks51
Efficacy of Melatonin in Alleviating Radiotherapy-Induced Fatigue, Anxiety, and Depression in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
2025 · intervention group · Women aged 18–65 with breast cancer receiving adjuvant radiotherapy
20 mg—50
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder
2021 · Placebo group, then open-label PedPRM · Children and adolescents aged 2–17.5 years with autism spectrum disorder or Smith-Magenis syndrome and impaired sleep
2 mg104 weeks44
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
2014 · PRM (prolonged-release melatonin) · Adults aged 50–85 with mild to moderate Alzheimer’s disease receiving stable standard Alzheimer’s therapy
2 mg24 weeks39
A Randomized, Controlled, Parallel-Group, Trial on the Effects of Melatonin on Fatigue Associated with Breast Cancer and Its Adjuvant Treatments
2021 · intervention group (oral melatonin) · Women with stage I–III invasive breast cancer receiving adjuvant chemotherapy and radiotherapy
18 mg25 weeks38
Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach
1999 · Melatonin group, period 2 · Adults with insomnia receiving benzodiazepine therapy; age and sex not specified
2 mg6 weeks34
Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial
2018 · melatonin treatment · Adults aged 18–65 with traumatic brain injury and chronic insomnia
2 mg4 weeks33
Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial
2018 · melatonin treatment · Adults aged 18–65 with traumatic brain injury and chronic insomnia
2 mg4 weeks33
Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway
2007 · sulpiride plus melatonin · Patients with subjective tinnitus; age and sex not reported
3 mg30 days30
The effect of long-term melatonin supplementation on psychosomatic disorders in postmenopausal women
2018 · Group II — melatonin · Postmenopausal women aged 51–64 years
8 mg1 year30
Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial
2023 · treatment · women aged over 55 years with nocturia
2 mg2 weeks30
Effects of melatonin administration on daytime sleep after simulated night shift work
2001 · Melatonin session · Healthy adults aged 18–37 years, women and men, without stated medical, psychiatric, or sleep disorders, undergoing simulated night-shift work
1.8 mg2 days21
Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs
1997 · controlled-release melatonin · Elderly people with insomnia, low melatonin output, and benzodiazepine treatment
2 mg3 weeks21
Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement
2004 · melatonin · Older men with urodynamically confirmed bladder outflow obstruction and nocturia
2 mg4 weeks20
Effects of melatonin and rilmazafone on nocturia in the elderly
2007 · melatonin · Elderly patients with nocturia
2 mg4 weeks20
Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
2016 · Prolonged-release melatonin (PRM) · Adults aged 18 years or older with schizophrenia, schizoaffective disorder, or euthymic bipolar disorder, receiving antipsychotic treatment and long-term benzodiazepine or benzodiazepine-like treatment
2 mg24 weeks20
Melatonin Supplementation for Six Weeks Had No Effect on Arterial Stiffness and Mitochondrial DNA in Women Aged 55 Years and Older with Insomnia: A Double-Blind Randomized Controlled Study
2021 · melatonin group · Women aged 55 years and older with insomnia (PSQI ≥5)
2 mg6 weeks19
Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach
1999 · Melatonin group, period 1 · Adults with insomnia receiving benzodiazepine therapy; age and sex not specified
2 mg6 weeks18
Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial
2020 · Melatonin · Women aged 18–75 with breast cancer scheduled for their first cycle of adjuvant chemotherapy
20 mg10 days18
Improvement of sleep quality in elderly people by controlled-release melatonin
1995 · controlled-release melatonin · Elderly people aged 76 years on average with insomnia and chronic illnesses
2 mg3 weeks12
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
2007 · prolonged-release melatonin · Adults aged 55 years and older with primary insomnia
2 mg3 weeks—
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial
2008 · Melatonin with dim light · Elderly group-care residents, mean age 85.8 years; 90% female and 87% with dementia
2.5 mg1278 days—
Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial
2008 · Melatonin with bright light · Elderly group-care residents, mean age 85.8 years; 90% female and 87% with dementia
2.5 mg1278 days—
The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
2009 · prolonged-release melatonin (PRM) · Patients aged ≥55 years with primary insomnia; sex not specified
2 mg3 weeks—
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
2011 · PRM (prolonged-release melatonin) · Males and females aged 18–80 years with primary insomnia and mean nightly sleep latency greater than 20 minutes
2 mg29 weeks—
Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial
2012 · 2.5 mg melatonin · Adults aged 45–64 with hypertension treated with atenolol or metoprolol
2.5 mg3 weeks—
Melatonin effects on myocardial ischemia-reperfusion injury: Impact on the outcome in patients undergoing coronary artery bypass grafting surgery
2016 · high dose melatonin treatment group (M2) · Patients undergoing elective coronary artery bypass graft surgery
20 mg——
Melatonin supplementation may benefit patients with acute ischemic stroke not eligible for reperfusion therapies: Results of a pilot study
2022 · melatonin · Patients with acute ischemic stroke not eligible for reperfusion therapy; age and sex not reported
20 mg5 days—
Is there a role for melatonin in the treatment of neoplastic cachexia?
1996 · supportive care plus MLT · patients with untreatable metastatic solid tumours
20 mg90 days—
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
1998 · 2-mg controlled-release (CR) formulation · Volunteers who had flights over 6 to 8 time zones; age and sex not stated
2 mg4 days—
Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study
2000 · melatonin · Mild to moderate essential hypertensive outpatients; age and sex not reported
5 mg4 weeks47
Study on the Effects of Melatonin on Glycemic Control and Periodontal Parameters in Patients with Type II Diabetes Mellitus and Periodontal Disease
2021 · study group · Adults with type 2 diabetes and chronic periodontitis; mean age 53.24 years
3 mg8 weeks27
Consumption of melatonin supplement improves cardiovascular disease risk factors and anthropometric indices in type 2 diabetes mellitus patients: a double-blind, randomized, placebo-controlled trial
2021 · intervention group · Men and women aged 30–60 with type 2 diabetes mellitus diagnosed more than 5 years earlier
3 mg8 weeks25
Blood pressure response to melatonin in type 1 diabetes
2004 · melatonin treatment phase · Adolescents aged 14–18: 11 normotensive, normoalbuminuric patients with type 1 diabetes and 10 healthy controls
5 mg7 days21
Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial
2014 · melatonin · Adults with bipolar disorder or schizophrenia treated with second-generation antipsychotics
5 mg8 weeks20
Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial
2015 · 3 mg melatonin · Postmenopausal women with osteopenia, mean age 63 years (range 56–73)
3 mg1 year20
Prolonged melatonin administration decreases nocturnal blood pressure in women
2005 · slow-release melatonin · Women aged 47 to 63 years with normal blood pressure or treated essential hypertension
3 mg3 weeks18
[Effects of melatonin alone and in combination with aceten on chronostructure of diurnal hemodynamic rhythms in patients with hypertension stage II]
1999 · Group 1: melatonin alone · Patients with essential hypertension stage II; age and sex not reported
6 mg10 days10
Melatonin supplementation reduces nighttime blood pressure but does not affect blood pressure reactivity in normotensive adults on a high-sodium diet
2023 · HSD + MEL · Healthy normotensive men and women, mean age 26.5 years, on a high-sodium diet
10 mg10 days—
Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial
2014 · Melatonin · Adults undergoing elective surgery for abdominal aortic aneurysm
10 mg4 days26
The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double-blind study
2006 · Melatonin · Adults with ASA physical status I undergoing anesthetic induction
0.2 mg/kg1 day100
Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial
2018 · melatonin · Males and females aged 16–65 with delayed sleep-wake phase disorder and confirmed circadian delay
500 mcg4 weeks58
POTENTIAL USE OF MELATONIN IN PROCEDURAL ANXIETY AND PAIN IN CHILDREN UNDERGOING BLOOD WITHDRAWAL
2015 · melatonin · Children aged 1–14 years undergoing blood withdrawal
0.5 mg/kg1 day30
Comparing Intranasal Midazolam, Oral Melatonin, and Distraction Cards for Pain and Stress Management in Pediatric Intravenous Line Insertion: A Randomized Controlled Trial
2026 · Group 3: Administration of Oral Melatonin · Children aged 3–10 years with mild to moderate dehydration related to gastroenteritis undergoing intravenous line insertion in an emergency department
0.5 mg/kg1 day30
Oral melatonin, dexmedetomidine, and midazolam for prevention of postoperative agitation in children
2011 · group ML · Children aged 3–9 years undergoing esophageal dilatation under general anesthesia
0.1 mg/kg1 day25
The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial
2011 · supplemented group · Long-term care facility residents with primary insomnia; mean age 78.3 ± 3.9 years; sex not reported
5 mg8 weeks22
Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study
2012 · Melatonin · Students aged 14–19 years with sleep-onset difficulties during school weeks
1 mg6 days21
Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia
2003 · 0.1 mg melatonin · People with intellectual disability and sleep deficits/insomnia; age and sex not reported
100 mcg7 days20
A pilot study on the melatonin treatment in patients with early septic shock: results of a single-center randomized controlled trial
2022 · melatonin group · Adults aged 18–75 with early septic shock
50 mg5 days20
Melatonin treatment for age-related insomnia
2001 · 0.1 mg melatonin · Adults over 50 with actigraphically confirmed decreased sleep efficiency (insomniac subjects)
100 mcg7 days15
Melatonin treatment for age-related insomnia
2001 · 0.3 mg melatonin · Adults over 50 with actigraphically confirmed decreased sleep efficiency (insomniac subjects)
300 mcg7 days15
Melatonin treatment for age-related insomnia
2001 · 0.1 mg melatonin · Adults over 50 who slept normally
100 mcg7 days15
Melatonin treatment for age-related insomnia
2001 · 0.3 mg melatonin · Adults over 50 who slept normally
300 mcg7 days15
Effect of oral melatonin and wearing earplugs and eye masks on nocturnal sleep in healthy subjects in a simulated intensive care unit environment: which might be a more promising strategy for ICU sleep deprivation?
2015 · NLM (NL plus melatonin) · Healthy adults aged 24–64 years, men and women, exposed to simulated ICU noise and light
1 mg4 days10
The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study
2000 · 0.05 mg/kg melatonin group · Adult women undergoing surgery and receiving anesthetic premedication
0.05 mg/kg1 day—
The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study
2000 · 0.1 mg/kg melatonin group · Adult women undergoing surgery and receiving anesthetic premedication
0.1 mg/kg1 day—
Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study
2004 · melatonin · healthy elderly subjects
1 mg4 weeks—
Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial
2016 · 1 mg melatonin nightly · Postmenopausal women; age range not reported
1 mg1 year—
The effect of melatonin on early postoperative cognitive decline in elderly patients undergoing hip arthroplasty: A randomized controlled trial
2017 · melatonin · Patients older than 65 years (mean age 74.5 years; 53 male and 86 female) scheduled for hip arthroplasty
1 mg6 days—
Should Melatonin Be Used as an Alternative Sedative and Anxiolytic Agent in Mandibular Third Molar Surgery?
2019 · group M · Patients undergoing impacted third molar surgery
0.4 mg/kg1 day—
Melatonin as host modulating agent supporting nonsurgical periodontal therapy in patients affected by untreated severe periodontitis: A preliminary randomized, triple-blind, placebo-controlled study
2020 · melatonin group · People with untreated severe (stage III) periodontitis; age range and sex not reported
1 mg30 days—
High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults
2022 · low-dose melatonin condition · Healthy adults aged 55–78 years without major sleep complaints; 13 women and 11 men across the study
300 mcg12 days—
Attention-Deficit/Hyperactivity Disorder and Delayed Sleep Phase Syndrome in Adults: A Randomized Clinical Trial on the Effects of Chronotherapy on Sleep
2022 · melatonin · Adults aged 18–55 with ADHD and delayed sleep phase syndrome
500 mcg3 weeks—
Attention-Deficit/Hyperactivity Disorder and Delayed Sleep Phase Syndrome in Adults: A Randomized Clinical Trial on the Effects of Chronotherapy on Sleep
2022 · melatonin plus bright light therapy · Adults aged 18–55 with ADHD and delayed sleep phase syndrome
500 mcg3 weeks—
Randomized Clinical Trial of Antioxidant Therapy Patients with Septic Shock and Organ Dysfunction in the ICU: SOFA Score Reduction by Improvement of the Enzymatic and Non-Enzymatic Antioxidant System
2023 · Group 4 (MT) · Adults older than 18 years of any gender with septic shock admitted to the ICU
50 mg5 days—
Impact of Treatment with Antioxidants as an Adjuvant to Standard Therapy in Patients with Septic Shock: Analysis of the Correlation between Cytokine Storm and Oxidative Stress and Therapeutic Effects
2023 · Group 4 (MT) · Adults over 18 years of any gender with septic shock
50 mg5 days—
Low dose melatonin improves sleep in healthy middle-aged subjects
1996 · 0.3 mg melatonin · Healthy middle-aged volunteers
300 mcg1 day—
Low dose melatonin improves sleep in healthy middle-aged subjects
1996 · 1.0 mg melatonin · Healthy middle-aged volunteers
1 mg1 day—
Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag
1998 · 0.5-mg fast-release (FR) formulation · Volunteers who had flights over 6 to 8 time zones; age and sex not stated
500 mcg4 days—
Daily Melatonin Administration Attenuates Age-Dependent Disturbances of Cardiovascular Rhythms
2016 · melatonin group · Men and women aged 63–91 years, normotensive or hypertensive
1.5 mg2 weeks63
Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron-Overloaded Thalassemia Patients
2025 · melatonin group · Adults with thalassemia, osteopenia, and iron overload; mean age 30.8 years
20 mg1 year21
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
2004 · Repeated melatonin · Men with untreated essential hypertension
2.5 mg3 weeks16
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
2004 · Acute melatonin · Men with untreated essential hypertension
2.5 mg1 day16
[Effects of melatonin alone and in combination with aceten on chronostructure of diurnal hemodynamic rhythms in patients with hypertension stage II]
1999 · Group 2: aceten plus melatonin · Patients with essential hypertension stage II; age and sex not reported
6 mg10 days10
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial
2020 · Study group · Women undergoing ICSI
2 mg26 weeks50
Safety and efficacy of melatonin supplementation as an add-on treatment for infantile epileptic spasms syndrome: A randomized, placebo-controlled, double-blind trial
2024 · Melatonin group · Children aged 3 months to 2 years with infantile epileptic spasms syndrome
3 mg2 weeks35
The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia
2020 · Group IIIb (melatonin) · Postmenopausal women with chronic dyspepsia and Helicobacter pylori infection
4 mg26 weeks32
Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study
2005 · melatonin group · Patients with advanced gastrointestinal cancer, documented weight loss and/or decreased serum albumin, not amenable to standard anticancer treatment
18 mg8 weeks11
Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults
2012 · high dose 4 mg · Adults older than 65 with objective insomnia and low endogenous melatonin levels
4 mg6 weeks10
Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults
2012 · low dose 0.4 mg · Adults older than 65 with objective insomnia and low endogenous melatonin levels
400 mcg6 weeks9
Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial
2015 · 1 mg melatonin · Postmenopausal women with osteopenia, mean age 63 years (range 56–73)
1 mg1 year20
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy
2000 · melatonin, untreated postmenopausal women · postmenopausal women not receiving hormone replacement therapy
1 mg1 day—
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy
2000 · melatonin, postmenopausal women receiving hormone replacement therapy · postmenopausal women treated with transdermal estradiol and cyclic medroxyprogesterone acetate
1 mg1 day—
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial
2019 · melatonin group · Adults with type 2 diabetes and coronary heart disease; age and sex not reported
10 mg12 weeks30
Effect of pharmacological daytime doses of melatonin on human mood and performance
1993 · 10 mg melatonin · Healthy male volunteers
10 mg1 day20
A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapy
1999 · Capsule A (fast-release) · Healthy male volunteers
5 mg1 day15
A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapy
1999 · Capsule B (pulsatile dosage form) · Healthy male volunteers
10 mg1 day15
A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapy
1999 · Capsule C (pulsatile dosage form) · Healthy male volunteers
10 mg1 day15
Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis
2024 · 3 mg melatonin · Adults aged 18–65 with relapsing forms of multiple sclerosis receiving stable oral disease-modifying therapy
3 mg1 year15
Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis
2024 · 5 mg melatonin · Adults aged 18–65 with relapsing forms of multiple sclerosis receiving stable oral disease-modifying therapy
5 mg1 year15
Evaluation of an oral pulsatile delivery system for melatonin in humans
1998 · Capsule A (fast-release form) · Healthy male volunteers; age not reported
5 mg1 day15
Evaluation of an oral pulsatile delivery system for melatonin in humans
1998 · Capsule B (oral pulsatile delivery form) · Healthy male volunteers; age not reported
10 mg1 day15
Evaluation of an oral pulsatile delivery system for melatonin in humans
1998 · Capsule C (oral pulsatile delivery form) · Healthy male volunteers; age not reported
10 mg1 day15
Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia
2005 · Melatonin group (administration at 18:00 or 19:00) · Children aged 6–12 years with idiopathic chronic sleep onset insomnia
5 mg4 weeks—
The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial
2019 · intervention group · People with type 2 diabetes mellitus and chronic periodontitis; age and sex not specified
6 mg——
Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study
2024 · Treatment group · Adults younger than 60 years with COVID-19 or COVID-like illness, no previous medical history, and not hospitalized
2 mg—82
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)
2024 · melatonin treatment group · Healthy adults aged 18–64 years planning to receive influenza vaccination
5 mg2 weeks53
Exogenous melatonin boosts vaccine-induced immunity in individuals with high pre-existing influenza immunity
2025 · Melatonin treatment · Healthy adults aged 18–64 years receiving seasonal influenza vaccination; the reported high- and low-baseline HAI subgroups had elevated or lower pre-existing A/Victoria HAI titers, respectively.
5 mg2 weeks53
Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial
2022 · Melatonin · Adults aged 30–82 with symptomatic, clinically stable heart failure with reduced ejection fraction (NYHA class II or III)
10 mg24 weeks46
Metabolic and Anti-inflammatory Response to Melatonin Administration in Patients with Diabetic Nephropathy
2021 · melatonin · Patients with diabetic nephropathy; age and sex not specified
10 mg12 weeks30
A Randomized Control Trial Study to Determine the Effect of Melatonin on Serum Levels of IL-1β and TNF-α in Patients with Multiple Sclerosis
2019 · treatment group · patients with multiple sclerosis; age and sex not specified
3 mg24 weeks25
Effect of oral melatonin on the procoagulant response to acute psychosocial stress in healthy men: a randomized placebo-controlled study
2008 · melatonin · Healthy young men
3 mg1 day24
A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women
2015 · melatonin · Obese women; age not stated
6 mg40 days22
Effects of melatonin on advanced glycation end products, inflammation, and oxidative stress in peritoneal dialysis patients: a randomized controlled trial
2025 · melatonin group · Adults aged 19–75 with chronic kidney failure undergoing continuous ambulatory peritoneal dialysis
5 mg10 weeks22
Evaluating the antioxidant and anti-inflammatory effect of melatonin in pediatric hemodialysis patients: a randomized, placebo-controlled trial
2026 · MLT group · Children aged 6–18 years with end-stage renal disease receiving maintenance hemodialysis
5 mg12 weeks20
The effect of preoperative melatonin on nuclear erythroid 2-related factor 2 activation in patients undergoing coronary artery bypass grafting surgery
2013 · Melatonin group (Group I) · Adults aged 41–75 undergoing elective coronary artery bypass grafting surgery
10 mg30 days15
12-week melatonin intake attenuates cardiac autonomic dysfunction and oxidative stress in multiple sclerosis patients: a randomized controlled trial
2024 · melatonin group (MG) · People with multiple sclerosis; age range and sex not stated
3 mg12 weeks15
Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double-blind, placebo-controlled trial
2021 · melatonin group · Females with systemic lupus erythematosus (SLE); age not reported
10 mg12 weeks13
Phase advance with separate and combined melatonin and light treatment
2011 · melatonin · 11 subjects; age, sex, and health status not reported
3 mg1 day11
Phase advance with separate and combined melatonin and light treatment
2011 · melatonin plus light · 11 subjects; age, sex, and health status not reported
3 mg1 day11
The effect of melatonin administration on pituitary hormone secretion in man
1999 · 5.0 mg melatonin · Healthy men, mean age 21 years
5 mg1 day8
[Melatonin reduces cortisol response to ACTH in humans]
2008 · melatonin · Eight young healthy males pretreated with dexamethasone
6 mg1 day8
Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase
1995 · Melatonin during follicular phase · Normal cycling women studied during the follicular phase (cycle days 4–6)
3 mg2 days8
Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase
1995 · Melatonin during luteal phase · Normal cycling women studied during the luteal phase (cycle days 19–21)
3 mg2 days8
Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone
1993 · Study 1: oral melatonin · Normal males aged 22–35 years
10 mg1 day8
Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone
1993 · Study 3: oral melatonin · Normal males aged 22–35 years
10 mg1 day8
Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone
1993 · Study 3: melatonin plus pyridostigmine · Normal males aged 22–35 years
10 mg1 day8
Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone
1993 · Study 4: oral melatonin before submaximal GHRH · Normal males aged 22–35 years
10 mg1 day8
Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone
1993 · Study 4: melatonin plus pyridostigmine before submaximal GHRH · Normal males aged 22–35 years
10 mg1 day8
The hypothermic effect of melatonin on core body temperature: is more better?
1996 · 5.0 mg melatonin · Healthy adults aged 18–38 years
5 mg1 day8
Exercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjects
1999 · melatonin · Seven healthy adult male subjects
5 mg1 day7
Hypothermic action of exogenously administered melatonin is dose-dependent in humans
2001 · 3 mg exogenous melatonin · Healthy young men aged 19–24 years
3 mg1 day6
Hypothermic action of exogenously administered melatonin is dose-dependent in humans
2001 · 9 mg exogenous melatonin · Healthy young men aged 19–24 years
9 mg1 day6
Hypnotic and hypothermic action of daytime-administered melatonin
1997 · 3 mg melatonin condition · Healthy men, average age 22.5 years
3 mg1 day6
Hypnotic and hypothermic action of daytime-administered melatonin
1997 · 9 mg melatonin condition · Healthy men, average age 22.5 years
9 mg1 day6
Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil
1999 · placebo-melatonin · Six healthy young adult men
3 mg1 day—
Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil
1999 · flumazenil-melatonin · Six healthy young adult men
3 mg1 day—
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients
1992 · IL-2 once daily plus MLT at 10 mg/day · Advanced cancer patients; age and sex not reported
10 mg4 weeks—
Melatonin administration to blind people: phase advances and entrainment
1991 · melatonin group · totally blind men with free-running endogenous melatonin rhythms
5 mg3 weeks—
Melatonin treatment for eastward and westward travel preparation
2010 · 3 mg regular release (RR) · Subjects; age, sex, and health status not specified
3 mg1 day—
Melatonin treatment for eastward and westward travel preparation
2010 · 3 mg sustained release (SR) · Subjects; age, sex, and health status not specified
3 mg1 day—
Combination of light and melatonin time cues for phase advancing the human circadian clock
2013 · dim light-melatonin · Healthy adults aged 22 ± 4 years; 18 of the 36 participants were female
5 mg1 day—
Combination of light and melatonin time cues for phase advancing the human circadian clock
2013 · bright light-melatonin · Healthy adults aged 22 ± 4 years; 18 of the 36 participants were female
5 mg1 day—
The protective effect of melatonin on smoke-induced vascular injury in rats and humans: a randomized controlled trial
2016 · melatonin · smokers; age and sex not specified
3 mg2 weeks—
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
2017 · melatonin group · Critically ill adults in an ICU with an estimated mechanical ventilation duration over 8 days
6 mg——
The protective effect of melatonin on brain ischemia and reperfusion in rats and humans: In vivo assessment and a randomized controlled trial
2018 · melatonin · Patients with carotid stenosis undergoing carotid endarterectomy; age and sex not stated
6 mg6 days—
Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study
2019 · ST-OS · High-risk critically ill patients
3 mg1 day—
Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study
2019 · SLN-OS · High-risk critically ill patients
3 mg1 day—
The effect of oral melatonin on renal ischemia-reperfusion injury in transplant patients: A double-blind, randomized controlled trial
2019 · melatonin group · Renal transplant candidates; age and sex not reported
3 mg——
Melatonin ingestion before intradialytic exercise improves immune responses in hemodialysis patients
2021 · EX + MEL · Hemodialysis patients; age and sex not reported
3 mg1 day—
Melatonin ingestion before intradialytic exercise improves immune responses in hemodialysis patients
2021 · CON + MEL · Hemodialysis patients; age and sex not reported
3 mg1 day—
Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans
1995 · 5 mg melatonin · 6 healthy volunteers; age and sex not reported
5 mg1 day—
Adapting to phase shifts, II. Effects of melatonin and conflicting light treatment
1996 · MT · volunteers; age, sex, and health condition not stated
5 mg3 days—
Adapting to phase shifts, II. Effects of melatonin and conflicting light treatment
1996 · MT+BL · volunteers; age, sex, and health condition not stated
5 mg3 days—
Effect of pharmacological daytime doses of melatonin on human mood and performance
1993 · 20 mg melatonin · Healthy male volunteers
20 mg1 day20
Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
2022 · Oniria prolonged-release melatonin · Healthy men and women aged 20–45 years without relevant clinical conditions or analytical alterations
1.98 mg1 day14
Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
2022 · Immediate-release melatonin (Melatoplus) · Healthy men and women aged 20–45 years without relevant clinical conditions or analytical alterations
1.99 mg1 day14
Dose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsis
2022 · 20 mg dose cohort · Adults older than 16 with sepsis due to community-acquired pneumonia admitted to ICU or medical high dependency unit; four male and one female, aged 45–83 years
20 mg1 day5
The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study
2006 · melatonin without CYP2C19 substrate · Elderly psychogeriatric inpatients with insomnia, without a CYP2C19 substrate
2 mg3 weeks—
The effect of CYP2C19 substrate on the metabolism of melatonin in the elderly: A randomized, double-blind, placebo-controlled study
2006 · melatonin with CYP2C19 substrate · Elderly psychogeriatric inpatients with insomnia who were receiving a CYP2C19 substrate (citalopram, omeprazole, or lansoprazole)
2 mg3 weeks—
Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women
2012 · melatonin · Perimenopausal women aged 45–54
3 mg26 weeks13
The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial
2019 · study group · Patients with rectal cancer undergoing radiotherapy
20 mg4 weeks30
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
2001 · melatonin alone · Patients with cancer-related thrombocytopenia who had not responded to melatonin alone
20 mg—16
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system
2002 · IL-2 plus MLT alone · Patients with untreatable metastatic solid tumors
20 mg4 weeks14
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system
2002 · IL-2 plus MLT plus NTX · Patients with untreatable metastatic solid tumors
20 mg4 weeks14
The effect of melatonin on glucose tolerance, insulin sensitivity and lipid profiles after a late evening meal in healthy young males
2021 · DSC (dark + exogenous melatonin) · Healthy male students, mean age 26 years
2 mg1 day9
The effect of melatonin on glucose tolerance, insulin sensitivity and lipid profiles after a late evening meal in healthy young males
2021 · LSC (light + exogenous melatonin) · Healthy male students, mean age 26 years
2 mg1 day9
Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod
2007 · Melatonin · Healthy males, mean age 24.4 years
1.5 mg9 days8
Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
2015 · melatonin · Men with stable, complete tetraplegia; age range not reported
2 mg4 days6
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
2015 · melatonin supplementation · Six men with long-standing complete tetraplegia
2 mg4 days6
Amplification of pulsatile LH secretion by exogenous melatonin in women
1991 · 2.5 mg melatonin in three divided doses group · Women in the early follicular phase (cycle days 2–5)
2.5 mg2 days5
Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin
2006 · melatonin and zinc alone · Patients with type 2 diabetes mellitus and inadequate response to metformin
10 mg90 days—
Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin
2006 · melatonin and zinc with metformin · Patients with type 2 diabetes mellitus and inadequate response to metformin
10 mg90 days—
Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up
2014 · Group II · Patients with NAFLD confirmed by liver biopsy; age and sex not reported
10 mg426 days—
Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
1997 · chemotherapy plus MLT · Patients with metastatic solid tumors in poor clinical condition: lung cancer, breast cancer, or gastrointestinal tract tumors; age and sex not reported
20 mg——
Antioxidant Effect of Melatonin in Preterm Newborns
2021 · MEL group · Preterm newborns born before 37 weeks’ gestation
0.5 mg/kg7 days21
Effect of pharmacological daytime doses of melatonin on human mood and performance
1993 · 40 mg melatonin · Healthy male volunteers
40 mg1 day20
Effect of pharmacological daytime doses of melatonin on human mood and performance
1993 · 80 mg melatonin · Healthy male volunteers
80 mg1 day20
Effect of Red Wine Intake on Serum and Salivary Melatonin Levels: A Randomized, Placebo-Controlled Clinical Trial
2018 · MLT+ wine · Healthy, normal-weight adults aged 20–45 years; seven males and five females were recruited
1.25 mcg1 day12
Dose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsis
2022 · 50 mg dose cohort · Adults older than 16 with sepsis due to community-acquired pneumonia admitted to ICU or medical high dependency unit; all male, aged 54–70 years
50 mg1 day5
Feasibility and functionality of OROS melatonin in healthy subjects
1999 · 1 × 110 micrograms · Healthy adults aged 60–73 years with no sleep disorders
110 mcg1 day—
Feasibility and functionality of OROS melatonin in healthy subjects
1999 · 4 × 110 micrograms · Healthy adults aged 60–73 years with no sleep disorders
110 mcg1 day—
Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial
2022 · melatonin alone · Patients with primary pneumosepsis; age and sex not reported
20 mg——
Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease
2020 · melatonin · Patients with stage 1–3 Parkinson's disease
50 mg90 days26
Usefulness of Antioxidants as Adjuvant Therapy for Septic Shock: A Randomized Clinical Trial
2020 · MT · Adults of either sex with septic shock
50 mg5 days20
Acute metabolic effects of melatonin-A randomized crossover study in healthy young men
2021 · Melatonin · Healthy young men
40 mg1 day20
Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT
2010 · 0.1 mg/kg melatonin group · Children aged 6–12 years with chronic sleep onset insomnia
0.1 mg/kg7 days19
Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT
2010 · 0.15 mg/kg melatonin group · Children aged 6–12 years with chronic sleep onset insomnia
0.15 mg/kg7 days18
Melatonin ameliorates inflammation and improves outcomes of ischemia/reperfusion injury in patients undergoing coronary artery bypass grafting surgery: a randomized placebo-controlled study
2025 · Melatonin-treated group (MTG) · Adults undergoing elective on-pump coronary artery bypass grafting surgery; ages 56.6 ± 8.031 years in the melatonin group; patients with coronary heart disease
60 mg5 days17
Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT
2010 · 0.05 mg/kg melatonin group · Children aged 6–12 years with chronic sleep onset insomnia
0.05 mg/kg7 days16
Essential Hypertension and Oxidative Stress: Novel Future Perspectives
2022 · melatonin group · Adults aged 40–60 years with essential hypertension
1 mg1 year16
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement
2000 · melatonin · Healthy postmenopausal women
1 mg1 day14
Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia
2001 · melatonin plus 5-methoxytryptamine · Patients with cancer-related thrombocytopenia who had not responded to melatonin alone
20 mg—14
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration
2001 · Melatonin with recombinant human erythropoietin · Adults with end-stage renal failure receiving chronic hemodialysis
0.3 mg/kg1 day9
The effect of melatonin administration on pituitary hormone secretion in man
1999 · 0.05 mg melatonin · Healthy men, mean age 21 years
50 mcg1 day8
The effect of melatonin administration on pituitary hormone secretion in man
1999 · 0.5 mg melatonin · Healthy men, mean age 21 years
500 mcg1 day8
Melatonin enhances cortisol levels in aged but not young women
1995 · melatonin, aged women · Women aged 54–62 years who were postmenopausal
100 mg2 days8
The hypothermic effect of melatonin on core body temperature: is more better?
1996 · 0.1 mg melatonin · Healthy adults aged 18–38 years
100 mcg1 day8
The hypothermic effect of melatonin on core body temperature: is more better?
1996 · 0.5 mg melatonin · Healthy adults aged 18–38 years
500 mcg1 day8
The hypothermic effect of melatonin on core body temperature: is more better?
1996 · 1.0 mg melatonin · Healthy adults aged 18–38 years
1 mg1 day8
Melatonin enhances cortisol levels in aged women: reversible by estrogens
1997 · melatonin · Seven aged postmenopausal women
100 mg2 days7
Hypothermic action of exogenously administered melatonin is dose-dependent in humans
2001 · 0.5 mg exogenous melatonin · Healthy young men aged 19–24 years
500 mcg1 day6
Amplification of pulsatile LH secretion by exogenous melatonin in women
1991 · 100 mg single-dose melatonin group · Women in the early follicular phase (cycle days 2–5)
100 mg2 days6
Melatonin enhances cortisol levels in aged but not young women
1995 · melatonin, young women · Women aged 22–32 years in the early follicular phase
100 mg2 days6
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy
2001 · melatonin · Postmenopausal women, including women with and without hormone replacement therapy
1 mg1 day—
Effects of exogenous melatonin on pituitary hormones in humans
2001 · exogenous melatonin · Healthy adults and patients with sleep disorders; ages and sex not specified
1 mg1 day—
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients
1992 · IL-2 once daily plus MLT at 50 mg/day · Advanced cancer patients; age and sex not reported
50 mg4 weeks—
The benefit of a supplement with the antioxidant melatonin on redox status and muscle damage in resistance-trained athletes
2017 · melatonin · Resistance-trained athletes
100 mg4 weeks—
[Effect of melatonin administration on cyclooxygenase-2 activity, serum levels of nitric oxide metabolites, lipoperoxides and glutathione peroxidase activity in patients with Parkinson’s disease]
2017 · MEL · Patients with Parkinson's disease
50 mg1 year—
Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis
2018 · experimental group · Adults with relapsing-remitting multiple sclerosis treated with interferon β-1b
25 mg26 weeks—
Melatonin a Promising Candidate for DNA Double-Stranded Breaks Reduction in Patients Undergoing Abdomen-Pelvis Computed Tomography Examinations
2020 · group two · Patients undergoing abdomen-pelvis CT examinations
100 mg1 day—
Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial
2021 · melatonin · Adults aged 18–55 with ADHD and delayed sleep phase syndrome
500 mcg3 weeks—
Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial
2021 · melatonin plus bright light therapy · Adults aged 18–55 with ADHD and delayed sleep phase syndrome
500 mcg3 weeks—
Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson's Disease
2021 · melatonin-placebo group (melatonin phase) · Adults over 20 years old with stage 1–3 Parkinson's disease
50 mg90 days—
The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial
2022 · melatonin group · female patients with hyperthyroidism
300 mg1 day—
Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial
2022 · propolis plus melatonin · Patients with primary pneumosepsis; age and sex not reported
20 mg——
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin
1994 · TNF plus MLT · patients with metastatic solid tumors for whom no effective standard antitumor therapy was available
40 mg12 days—
Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans
1995 · 0.05 mg melatonin · 6 healthy volunteers; age and sex not reported
50 mcg1 day—
Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans
1995 · 0.5 mg melatonin · 6 healthy volunteers; age and sex not reported
500 mcg1 day—
Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients
1995 · Low-dose IL-2 plus melatonin · Patients with gastrointestinal tract tumors undergoing surgery; age and sex not reported
40 mg5 days—
Influences of melatonin administration on the circulation of women
1998 · melatonin · 17 young, healthy, early follicular-phase women
1 mg1 day—
Myo-inositol and melatonin in the menopausal transition
2017 · myo-inositol plus melatonin group · Women aged 45–55 years with at least 6 months of amenorrhea during the menopausal transition
3 g26 weeks20
Melatonin prevents oxidative stress resulting from iron and erythropoietin administration
2001 · Melatonin with intravenous iron · Adults with end-stage renal failure receiving chronic hemodialysis
0.3 mg/kg1 day9
Contemporaneous melatonin administration modifies the circadian response to nocturnal bright light stimuli
1997 · melatonin · Women; no age range or condition reported
1.75 mg3 days5
New chitin complexes and their anti-aging activity from inside out
2012 · ORAL MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · ORAL CN-MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group A · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
3 mg——
New chitin complexes and their anti-aging activity from inside out
2012 · COMBINED MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · COMBINED CN-MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—